Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
34.55 INR
4.71 B INR
22.70 B INR
30.64 M
About ALIVUS LIFE SCIENCES LTD
Sector
CEO
Yasir Rawjee
Headquarters
Mumbai
Website
Founded
2011
ISIN
INE03Q201024
FIGI
BBG011WT9KP6
Alivus Life Sciences Ltd. engages in the provision of development and manufacture of non-commoditized active pharmaceutical ingredients. It operates through the Within India and Outside India geographical segments. Its products focus on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALIVUS is 1,149.90 INR — it has increased by 2.11% in the past 24 hours. Watch ALIVUS LIFE SCIENCES LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange ALIVUS LIFE SCIENCES LTD stocks are traded under the ticker ALIVUS.
ALIVUS stock has risen by 13.37% compared to the previous week, the month change is a 10.90% rise, over the last year ALIVUS LIFE SCIENCES LTD has showed a 46.30% increase.
We've gathered analysts' opinions on ALIVUS LIFE SCIENCES LTD future price: according to them, ALIVUS price has a max estimate of 1,200.00 INR and a min estimate of 1,015.00 INR. Watch ALIVUS chart and read a more detailed ALIVUS LIFE SCIENCES LTD stock forecast: see what analysts think of ALIVUS LIFE SCIENCES LTD and suggest that you do with its stocks.
ALIVUS stock is 10.84% volatile and has beta coefficient of −0.04. Track ALIVUS LIFE SCIENCES LTD stock price on the chart and check out the list of the most volatile stocks — is ALIVUS LIFE SCIENCES LTD there?
Yes, you can track ALIVUS LIFE SCIENCES LTD financials in yearly and quarterly reports right on TradingView.
ALIVUS LIFE SCIENCES LTD is going to release the next earnings report on Jan 23, 2025. Keep track of upcoming events with our Earnings Calendar.
ALIVUS LIFE SCIENCES LTD revenue for the last quarter amounts to 5.07 B INR, despite the estimated figure of 5.78 B INR. In the next quarter, revenue is expected to reach 5.90 B INR.
ALIVUS net income for the last quarter is 953.16 M INR, while the quarter before that showed 1.11 B INR of net income which accounts for −14.50% change. Track more ALIVUS LIFE SCIENCES LTD financial stats to get the full picture.
ALIVUS LIFE SCIENCES LTD dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 11.11% and 114.14% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jan 21, 2025, the company has 3.47 K employees. See our rating of the largest employees — is ALIVUS LIFE SCIENCES LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALIVUS LIFE SCIENCES LTD EBITDA is 6.08 B INR, and current EBITDA margin is 29.67%. See more stats in ALIVUS LIFE SCIENCES LTD financial statements.
Like other stocks, ALIVUS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALIVUS LIFE SCIENCES LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALIVUS LIFE SCIENCES LTD technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALIVUS LIFE SCIENCES LTD stock shows the strong buy signal. See more of ALIVUS LIFE SCIENCES LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.